MobiHealth News July 9, 2019
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
Cloud-based computing could offer major benefits to pharmaceutical companies in the area of drug development as they grapple with rising costs and avalanches of data that need to be collected, analyzed and shared.
In particular, the technology could help streamline operations and develop business cases as to whether a drug is likely to be needed — or financially viable.
“If you’ve got big pots of data that tell you conventional antibiotics aren’t solving a particular malady that a large percentage of the population is suffering from, you could essentially use that data to put together a business case to develop a drug to meet the...
Today's Sponsors
Today's Sponsor